Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Sachin Wani to Esophageal Neoplasms

This is a "connection" page, showing publications Sachin Wani has written about Esophageal Neoplasms.

 
Connection Strength
  
 
 
24.504
  
  1. Enke T, Pokala SK, Hensen C, Brennan C, Gallegos J, Hochheimer CJ, Muthusamy VR, Thaker AM, Kushnir V, Early D, Rastogi A, Hammad H, Edmundowicz SA, Komanduri S, Wani S. Recurrent Barrett's esophagus-related neoplasia is uncommon after successful endoscopic eradication therapy over long-term follow-up. Dis Esophagus. 2026 Jan 09; 39(1).
    View in: PubMed
    Score: 0.698
  2. Zhou MJ, Sawas T, Leiman DA, Wani S. Clinical Utility of Biomarkers for Barrett's Esophagus: Guidelines and Future Directions. Gastroenterol Clin North Am. 2026 Mar; 55(1):21-37.
    View in: PubMed
    Score: 0.690
  3. Wani S, Zhou MJ, Sawas T, Rubenstein JH, Eluri S, Leiman DA, Sultan S, Singh S, Inadomi J, Thrift AP, Katzka DA, Davitkov P. AGA Clinical Practice Guideline on Surveillance of Barrett's Esophagus. Gastroenterology. 2025 11; 169(6):1184-1231.
    View in: PubMed
    Score: 0.689
  4. Pokala SK, Lagergren J, Wani S. Emerging Challenges of Postendoscopy Esophageal Adenocarcinoma and Postendoscopy Esophageal Neoplasia. Gastrointest Endosc Clin N Am. 2026 Jan; 36(1):119-132.
    View in: PubMed
    Score: 0.687
  5. Wani S, Santoni G, Holmberg D, Kauppila JH, Farkkila M, Shaheen NJ, Lagergren J. Neoplasia Detection Rate and Risk of Post-endoscopy Esophageal Adenocarcinoma and Neoplasia in a Population-based Cohort Study. Clin Gastroenterol Hepatol. 2026 Mar; 24(3):667-677.
    View in: PubMed
    Score: 0.676
  6. Sawas T, Jones AR, Alsawas R, Talluri R, Rogers H, Bardhi O, Spezia-Lindner D, Gerberi D, Singh S, Murad MH, Shaheen NJ, Katzka DA, Wani S. Overall and Cause-Specific Mortality in Patients With Barrett's Esophagus: A Systematic Review and Meta-Analysis of Population-Based Studies. Am J Gastroenterol. 2026 Jan 01; 121(1):140-150.
    View in: PubMed
    Score: 0.661
  7. Kolb JM, Davis C, Williams JL, Holub J, Shaheen N, Wani S. High Rates of Dysplasia in a Population-Based Analysis of "Incidental" Barrett's Esophagus. Clin Gastroenterol Hepatol. 2026 May; 24(5):1280-1288.e3.
    View in: PubMed
    Score: 0.659
  8. Wani S. Approach to patients with positive vertical margins after endoscopic resection of Barrett's neoplasia. Endoscopy. 2024 08; 56(8):569-571.
    View in: PubMed
    Score: 0.621
  9. Pokala SK, Williams JL, Holub JL, Calderwood AH, Dominitz JA, Iyer PG, Shaheen NJ, Wani S. Significant Reduction in the Diagnosis of Barrett's Esophagus and Related Dysplasia During the COVID-19 Pandemic. Am J Gastroenterol. 2024 02 01; 119(2):251-261.
    View in: PubMed
    Score: 0.599
  10. Smith ZL, Thorgerson AM, Dawson AZ, Wani S. Incidence of Esophageal Adenocarcinoma, Mortality, and Esophagectomy in Barrett's Esophagus Patients Undergoing Endoscopic Eradication Therapy. Dig Dis Sci. 2023 12; 68(12):4439-4448.
    View in: PubMed
    Score: 0.598
  11. Wani S, Holmberg D, Santoni G, Kauppila JH, Farkkila M, von Euler-Chelpin M, Shaheen NJ, Lagergren J. Magnitude and Time-Trends of Post-Endoscopy Esophageal Adenocarcinoma and Post-Endoscopy Esophageal Neoplasia in a Population-Based Cohort Study: The Nordic Barrett's Esophagus Study. Gastroenterology. 2023 10; 165(4):909-919.e13.
    View in: PubMed
    Score: 0.583
  12. Kolb JM, Davis C, Williams JL, Holub J, Shaheen N, Wani S. Wide Variability in Dysplasia Detection Rate and Adherence to Seattle Protocol and Surveillance Recommendations in Barrett's Esophagus: A Population-Based Analysis Using the GIQuIC National Quality Benchmarking Registry. Am J Gastroenterol. 2023 05 01; 118(5):900-904.
    View in: PubMed
    Score: 0.565
  13. Kolb JM, Chen M, Tavakkoli A, Gallegos J, O'Hara J, Tarter W, Hochheimer CJ, Golubski B, Kopplin N, Hennessey L, Kalluri A, Devireddy S, Scott FI, Falk GW, Singal AG, Vajravelu RK, Wani S. Patient Knowledge, Risk Perception, and Barriers to Barrett's Esophagus Screening. Am J Gastroenterol. 2023 04 01; 118(4):615-626.
    View in: PubMed
    Score: 0.557
  14. Wani S, Souza RF, Durkalski VL, Serrano J, Hamilton F, Shaheen NJ. Multicenter Randomized Controlled Trial of Surveillance Versus Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia: The SURVENT Trial: Study Rationale, Methodology, Innovation, and Implications. Gastroenterology. 2022 09; 163(3):556-562.e4.
    View in: PubMed
    Score: 0.544
  15. Wani S. Personalized Approach to the Post-Endoscopic Eradication Therapy Barrett's Esophagus Patient. Gastroenterology. 2022 07; 163(1):39-42.
    View in: PubMed
    Score: 0.541
  16. Shaheen NJ, Falk GW, Iyer PG, Souza RF, Wani S. Guideline to Practice: Diagnosis and Management of Barrett's Esophagus: An Updated ACG Guideline. Am J Gastroenterol. 2022 08 01; 117(8):1177-1180.
    View in: PubMed
    Score: 0.539
  17. Shaheen NJ, Falk GW, Iyer PG, Souza RF, Yadlapati RH, Sauer BG, Wani S. Diagnosis and Management of Barrett's Esophagus: An Updated ACG Guideline. Am J Gastroenterol. 2022 04 01; 117(4):559-587.
    View in: PubMed
    Score: 0.537
  18. Kolb JM, Wani S. Endoscopic Management of Barrett's Esophagus. Dig Dis Sci. 2022 05; 67(5):1469-1479.
    View in: PubMed
    Score: 0.534
  19. Wani S, Yadlapati R, Singh S, Sawas T, Katzka DA. Post-endoscopy Esophageal Neoplasia in Barrett's Esophagus: Consensus Statements From an International Expert Panel. Gastroenterology. 2022 02; 162(2):366-372.
    View in: PubMed
    Score: 0.520
  20. Han S, Kolb JM, Hosokawa P, Friedman C, Fox C, Scott FI, Lieu CH, Vajravelu RK, McCarter M, Murphy CC, Cook MB, Gleisner A, Falk GW, Katzka DA, Wani S. The Volume-Outcome Effect Calls for Centralization of Care in Esophageal Adenocarcinoma: Results From a Large National Cancer Registry. Am J Gastroenterol. 2021 04; 116(4):811-815.
    View in: PubMed
    Score: 0.501
  21. Vajravelu RK, Kolb JM, Thanawala SU, Scott FI, Han S, Singal AG, Falk GW, Katzka DA, Wani S. Characterization of Prevalent, Post-Endoscopy, and Incident Esophageal Cancer in the United States: A Large Retrospective Cohort Study. Clin Gastroenterol Hepatol. 2022 08; 20(8):1739-1747.
    View in: PubMed
    Score: 0.496
  22. Jones B, Wani S. Endoscopic Eradication Therapy for Barrett's Neoplasia: Where Do We Stand a Decade Later? Curr Gastroenterol Rep. 2020 Dec 04; 22(12):61.
    View in: PubMed
    Score: 0.490
  23. Kolb JM, Wani S. A Paradigm Shift in Screening for Barrett's Esophagus: The BEST Is Yet to Come. Gastroenterology. 2021 01; 160(1):467-469.
    View in: PubMed
    Score: 0.489
  24. Wani S, Williams JL, Falk GW, Komanduri S, Muthusamy VR, Shaheen NJ. An Analysis of the GIQuIC Nationwide Quality Registry Reveals Unnecessary Surveillance Endoscopies in Patients With Normal and Irregular Z-Lines. Am J Gastroenterol. 2020 11; 115(11):1869-1878.
    View in: PubMed
    Score: 0.487
  25. Wani S. Advances and Opportunities in Barrett's Esophagus. Gastrointest Endosc Clin N Am. 2021 Jan; 31(1):xv-xvi.
    View in: PubMed
    Score: 0.486
  26. Wani S, Gyawali CP, Katzka DA. AGA Clinical Practice Update on Reducing Rates of Post-Endoscopy Esophageal Adenocarcinoma: Commentary. Gastroenterology. 2020 10; 159(4):1533-1537.
    View in: PubMed
    Score: 0.477
  27. Kolb JM, Wani S. Endoscopic eradication therapy for Barrett's oesophagus: state of the art. Curr Opin Gastroenterol. 2020 07; 36(4):351-358.
    View in: PubMed
    Score: 0.476
  28. Wani S, Han S, Kushnir V, Early D, Mullady D, Hammad H, Brauer B, Thaker A, Simon V, Ezekwe E, Hollander T, Wood M, Rastogi A, Edmundowicz S, Muthusamy VR, Komanduri S. Recurrence Is Rare Following Complete Eradication of Intestinal Metaplasia in Patients With Barrett's Esophagus and Peaks at 18 Months. Clin Gastroenterol Hepatol. 2020 10; 18(11):2609-2617.e2.
    View in: PubMed
    Score: 0.462
  29. Rubenstein JH, Waljee AK, Dwamena B, Bergman J, Vieth M, Wani S. Yield of Higher-Grade Neoplasia in Barrett's Esophagus With Low-Grade Dysplasia Is Double in the First Year Following Diagnosis. Clin Gastroenterol Hepatol. 2018 09; 16(9):1529-1530.
    View in: PubMed
    Score: 0.400
  30. Wani S, Gaddam S. Editorial: Best Practices in Surveillance of Barrett's Esophagus. Am J Gastroenterol. 2017 Jul; 112(7):1056-1060.
    View in: PubMed
    Score: 0.386
  31. Brimhall B, Wani S. Current Endoscopic Approaches for the Treatment of Barrett Esophagus. J Clin Gastroenterol. 2017 01; 51(1):2-11.
    View in: PubMed
    Score: 0.373
  32. Wani S, Komanduri S, Muthusamy VR. Endoscopic Eradication Therapy in Barrett's Esophagus-Related Neoplasia: Setting the Bar Right to Optimize Patient Outcomes. Gastroenterology. 2016 Mar; 150(3):772-4.
    View in: PubMed
    Score: 0.350
  33. Wani S, Das A, Rastogi A, Drahos J, Ricker W, Parsons R, Bansal A, Yen R, Hosford L, Jankowski M, Sharma P, Cook MB. Endoscopic ultrasonography in esophageal cancer leads to improved survival rates: results from a population-based study. Cancer. 2015 Jan 15; 121(2):194-201.
    View in: PubMed
    Score: 0.319
  34. Wani S, Drahos J, Cook MB, Rastogi A, Bansal A, Yen R, Sharma P, Das A. Comparison of endoscopic therapies and surgical resection in patients with early esophageal cancer: a population-based study. Gastrointest Endosc. 2014 Feb; 79(2):224-232.e1.
    View in: PubMed
    Score: 0.297
  35. Wani S, Abrams J, Edmundowicz SA, Gaddam S, Hovis CE, Green D, Gupta N, Higbee A, Bansal A, Rastogi A, Early D, Lightdale CJ, Sharma P. Endoscopic mucosal resection results in change of histologic diagnosis in Barrett's esophagus patients with visible and flat neoplasia: a multicenter cohort study. Dig Dis Sci. 2013 Jun; 58(6):1703-9.
    View in: PubMed
    Score: 0.289
  36. Wani S. Management of low-grade dysplasia in Barrett's esophagus. Curr Opin Gastroenterol. 2012 Jul; 28(4):370-6.
    View in: PubMed
    Score: 0.273
  37. Wani S, Falk GW, Post J, Yerian L, Hall M, Wang A, Gupta N, Gaddam S, Singh M, Singh V, Chuang KY, Boolchand V, Gavini H, Kuczynski J, Sud P, Bansal A, Rastogi A, Mathur SC, Young P, Cash B, Goldblum J, Lieberman DA, Sampliner RE, Sharma P. Risk factors for progression of low-grade dysplasia in patients with Barrett's esophagus. Gastroenterology. 2011 Oct; 141(4):1179-86, 1186.e1.
    View in: PubMed
    Score: 0.255
  38. Wani S. Population-based estimates of cancer and mortality in Barrett's esophagus: implications for the future. Clin Gastroenterol Hepatol. 2011 Sep; 9(9):723-4.
    View in: PubMed
    Score: 0.254
  39. Wani S, Falk G, Hall M, Gaddam S, Wang A, Gupta N, Singh M, Singh V, Chuang KY, Boolchand V, Gavini H, Kuczynski J, Sud P, Reddymasu S, Bansal A, Rastogi A, Mathur SC, Young P, Cash B, Lieberman DA, Sampliner RE, Sharma P. Patients with nondysplastic Barrett's esophagus have low risks for developing dysplasia or esophageal adenocarcinoma. Clin Gastroenterol Hepatol. 2011 Mar; 9(3):220-7; quiz e26.
    View in: PubMed
    Score: 0.245
  40. Wani S, Sayana H, Sharma P. Endoscopic eradication of Barrett's esophagus. Gastrointest Endosc. 2010 Jan; 71(1):147-66.
    View in: PubMed
    Score: 0.227
  41. Wani S, Puli SR, Shaheen NJ, Westhoff B, Slehria S, Bansal A, Rastogi A, Sayana H, Sharma P. Esophageal adenocarcinoma in Barrett's esophagus after endoscopic ablative therapy: a meta-analysis and systematic review. Am J Gastroenterol. 2009 Feb; 104(2):502-13.
    View in: PubMed
    Score: 0.215
  42. Wani S, Sharma P. Another strike against esophagectomy for high-grade dysplasia in Barrett's esophagus? Clin Gastroenterol Hepatol. 2008 Feb; 6(2):128-9.
    View in: PubMed
    Score: 0.201
  43. Holmberg D, Liljequist Aspelund A, Wani S, Ness-Jensen E, Von Euler-Chelpin M, Kauppila JH, Santoni G, Lagergren J. Survival in post-endoscopy esophageal cancer: a Nordic population-based cohort study. Endoscopy. 2026 Jun; 58(6):588-594.
    View in: PubMed
    Score: 0.175
  44. Sawas T, Benson JT, Allen A, Wang K, Wani S, Iyer PG, Katzka DA. The metabolic profile of lean patients with esophageal adenocarcinoma and Barrett's esophagus. Dis Esophagus. 2025 Nov 01; 38(6).
    View in: PubMed
    Score: 0.172
  45. Codipilly DC, Faghani S, Vogelsang D, Moassefi M, Garg N, Hagen C, Lewis J, Leggett CL, Patil P, Konda V, Al Diffalha S, Peter S, Brinkerhoff B, Wong M, Otaki F, Katzka DA, Wani S, Shaheen N, Erickson BJ, Iyer PG. Deep Learning Model for Histologic Diagnosis of Dysplastic Barrett's Esophagus: Multisite Cohort External Validation. Am J Gastroenterol. 2026 Apr 01; 121(4):863-870.
    View in: PubMed
    Score: 0.166
  46. Rubenstein JH, Sawas T, Wani S, Eluri S, Singh S, Chandar AK, Perumpail RB, Inadomi JM, Thrift AP, Piscoya A, Sultan S, Singh S, Katzka D, Davitkov P. AGA Clinical Practice Guideline on Endoscopic Eradication Therapy of Barrett's Esophagus and Related Neoplasia. Gastroenterology. 2024 06; 166(6):1020-1055.
    View in: PubMed
    Score: 0.156
  47. Sawas T, Wani S, Katzka DA. Endoscopic Surveillance After Endoscopic Eradication Therapy for Barrett's Esophagus With Neoplasia: Is the Vial Half Empty or Half Full? Gastroenterology. 2024 06; 166(6):963-964.
    View in: PubMed
    Score: 0.154
  48. Peabody JW, Cruz JDC, Ganesan D, Paculdo D, Critchley-Thorne RJ, Wani S, Shaheen NJ. A Randomized Controlled Study on Clinical Adherence to Evidence-Based Guidelines in the Management of Simulated Patients With Barrett's Esophagus and the Clinical Utility of a Tissue Systems Pathology Test: Results From Q-TAB. Clin Transl Gastroenterol. 2024 01 01; 15(1):e00644.
    View in: PubMed
    Score: 0.152
  49. Sijben J, Rainey L, Peters Y, Fitzgerald RC, Wani S, Kolb JM, Broeders MJM, Siersema PD. Dutch, UK and US professionals' perceptions of screening for Barrett's esophagus and esophageal adenocarcinoma: a concept mapping study. BMC Cancer. 2023 Nov 14; 23(1):1111.
    View in: PubMed
    Score: 0.150
  50. Dhaliwal L, Kamboj AK, Williams JL, Chandar AK, Sachdeva K, Gibbons E, Lansing R, Passe M, Perez JA, Avenir KLR, Martin SA, Leggett CL, Chak A, Falk GW, Wani S, Shaheen NJ, Kisiel JB, Iyer PG. Prevalence and Predictors of Barrett's Esophagus After Negative Initial Endoscopy: Analysis From Two National Databases. Clin Gastroenterol Hepatol. 2024 03; 22(3):523-531.e3.
    View in: PubMed
    Score: 0.149
  51. Davis C, Fuller A, Katzka D, Wani S, Sawas T. High Proportions of Newly Detected Visible Lesions and Pathology Grade Change Among Patients with Barrett's Esophagus Referred to Expert Centers. Dig Dis Sci. 2023 09; 68(9):3584-3595.
    View in: PubMed
    Score: 0.147
  52. Triggs JR, Krogh K, Simon V, Krause A, Kaplan JB, Yang GY, Wani S, Kahrilas PJ, Pandolfino J, Komanduri S. Novel histologic score predicts recurrent intestinal metaplasia after successful endoscopic eradication therapy. Dis Esophagus. 2023 Apr 29; 36(5).
    View in: PubMed
    Score: 0.145
  53. Cruz JD, Paculdo D, Ganesan D, Baker M, Critchley-Thorne RJ, Shaheen NJ, Wani S, Peabody JW. Clinical variation in surveillance and management of Barrett's esophagus: A cross-sectional study of gastroenterologists and gastrointestinal surgeons. Medicine (Baltimore). 2022 Dec 23; 101(51):e32187.
    View in: PubMed
    Score: 0.141
  54. Beveridge CA, Mittal C, Muthusamy VR, Rastogi A, Kushnir V, Wood M, Wani S, Komanduri S. Identification of visible lesions during surveillance endoscopy for Barrett's esophagus: a video-based survey study. Gastrointest Endosc. 2023 Feb; 97(2):241-247.e2.
    View in: PubMed
    Score: 0.138
  55. Muthusamy VR, Wani S, Gyawali CP, Komanduri S. AGA Clinical Practice Update on New Technology and Innovation for Surveillance and Screening in Barrett's Esophagus: Expert Review. Clin Gastroenterol Hepatol. 2022 12; 20(12):2696-2706.e1.
    View in: PubMed
    Score: 0.137
  56. Kolb JM, Chen M, Tavakkoli A, Singal AG, Vajravelu RK, Wani S. Understanding Compliance, Practice Patterns, and Barriers Among Gastroenterologists and Primary Care Providers Is Crucial for Developing Strategies to Improve Screening for Barrett's Esophagus. Gastroenterology. 2022 05; 162(6):1568-1573.e4.
    View in: PubMed
    Score: 0.133
  57. Mittal C, Muthusamy VR, Simon VC, Brauer BC, Mullady DK, Hollander T, Sloan I, Kushnir V, Early D, Rastogi A, Hammad HT, Edmundowicz SA, Han S, Thaker AM, Ezekwe E, Wani S, Kwasny MJ, Komanduri S. Threshold evaluation for optimal number of endoscopic treatment sessions to achieve complete eradication of Barrett's metaplasia. Endoscopy. 2022 10; 54(10):927-933.
    View in: PubMed
    Score: 0.133
  58. Sawas T, Majzoub AM, Haddad J, Tielleman T, Nayfeh T, Yadlapati R, Singh S, Kolb J, Vajravelu RK, Katzka DA, Wani S. Magnitude and Time-Trend Analysis of Postendoscopy Esophageal Adenocarcinoma: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2022 02; 20(2):e31-e50.
    View in: PubMed
    Score: 0.126
  59. Ho F, Torphy RJ, Friedman C, Leong S, Kim S, Wani S, Schefter T, Scott CD, Mitchell JD, Weyant MJ, Meguid RA, Gleisner AL, Goodman KA, McCarter MD. Induction Chemotherapy Plus Neoadjuvant Chemoradiation for Esophageal and Gastroesophageal Junction Adenocarcinoma. Ann Surg Oncol. 2021 Nov; 28(12):7208-7218.
    View in: PubMed
    Score: 0.126
  60. Kolb JM, Han S, Scott FI, Murphy CC, Hosokawa P, Wani S. Early-Onset Esophageal Adenocarcinoma Presents With Advanced-Stage Disease But Has Improved Survival Compared With Older Individuals. Gastroenterology. 2020 12; 159(6):2238-2240.e4.
    View in: PubMed
    Score: 0.120
  61. Kolb JM, Wani S, Soetikno R, Edmundowicz SA, Hammad H. Endoscopic submucosal dissection for early esophageal and gastric neoplasia in decompensated cirrhosis with varices. Endoscopy. 2021 Apr; 53(4):E128-E129.
    View in: PubMed
    Score: 0.120
  62. Qumseya B, Sultan S, Bain P, Jamil L, Jacobson B, Anandasabapathy S, Agrawal D, Buxbaum JL, Fishman DS, Gurudu SR, Jue TL, Kripalani S, Lee JK, Khashab MA, Naveed M, Thosani NC, Yang J, DeWitt J, Wani S. ASGE guideline on screening and surveillance of Barrett's esophagus. Gastrointest Endosc. 2019 09; 90(3):335-359.e2.
    View in: PubMed
    Score: 0.112
  63. Omar M, Thaker AM, Wani S, Simon V, Ezekwe E, Boniface M, Edmundowicz S, Obuch J, Cinnor B, Brauer BC, Wood M, Early DS, Lang GD, Mullady D, Hollander T, Kushnir V, Komanduri S, Muthusamy VR. Anatomic location of Barrett's esophagus recurrence after endoscopic eradication therapy: development of a simplified surveillance biopsy strategy. Gastrointest Endosc. 2019 09; 90(3):395-403.
    View in: PubMed
    Score: 0.109
  64. Everson MA, Lovat LB, Graham DG, Bassett P, Magee C, Alzoubaidi D, Fernández-Sordo JO, Sweis R, Banks MR, Wani S, Esteban JM, Ragunath K, Bisschops R, Haidry RJ. Virtual chromoendoscopy by using optical enhancement improves the detection of Barrett's esophagus-associated neoplasia. Gastrointest Endosc. 2019 02; 89(2):247-256.e4.
    View in: PubMed
    Score: 0.105
  65. Codipilly DC, Chandar AK, Singh S, Wani S, Shaheen NJ, Inadomi JM, Chak A, Iyer PG. The Effect of Endoscopic Surveillance in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis. Gastroenterology. 2018 06; 154(8):2068-2086.e5.
    View in: PubMed
    Score: 0.101
  66. Wani S, Qumseya B, Sultan S, Agrawal D, Chandrasekhara V, Harnke B, Kothari S, McCarter M, Shaukat A, Wang A, Yang J, Dewitt J. Endoscopic eradication therapy for patients with Barrett's esophagus-associated dysplasia and intramucosal cancer. Gastrointest Endosc. 2018 04; 87(4):907-931.e9.
    View in: PubMed
    Score: 0.101
  67. Qumseya BJ, Wani S, Gendy S, Harnke B, Bergman JJ, Wolfsen H. Disease Progression in Barrett's Low-Grade Dysplasia With Radiofrequency Ablation Compared With Surveillance: Systematic Review and Meta-Analysis. Am J Gastroenterol. 2017 Jun; 112(6):849-865.
    View in: PubMed
    Score: 0.095
  68. Mallick R, Patnaik SK, Wani S, Bansal A. A Systematic Review of Esophageal MicroRNA Markers for Diagnosis and Monitoring of Barrett's Esophagus. Dig Dis Sci. 2016 Apr; 61(4):1039-50.
    View in: PubMed
    Score: 0.086
  69. Yachimski P, Wani S, Givens T, Howard E, Higginbotham T, Price A, Berman K, Hosford L, Katcher PM, Ozanne E, Perzan K, Hur C. Preference of endoscopic ablation over medical prevention of esophageal adenocarcinoma by patients with Barrett's esophagus. Clin Gastroenterol Hepatol. 2015 Jan; 13(1):84-90.
    View in: PubMed
    Score: 0.077
  70. Bansal A, McGregor DH, Anand O, Singh M, Rao D, Cherian R, Wani SB, Rastogi A, Singh V, House J, Jones PG, Sharma P. Presence or absence of intestinal metaplasia but not its burden is associated with prevalent high-grade dysplasia and cancer in Barrett's esophagus. Dis Esophagus. 2014 Nov-Dec; 27(8):751-6.
    View in: PubMed
    Score: 0.075
  71. Tofteland N, Singh M, Gaddam S, Wani SB, Gupta N, Rastogi A, Bansal A, Kanakadandi V, McGregor DH, Ulusarac O, Cherian R, Mathur SC, Sharma P. Evaluation of the updated confocal laser endomicroscopy criteria for Barrett's esophagus among gastrointestinal pathologists. Dis Esophagus. 2014 Sep-Oct; 27(7):623-9.
    View in: PubMed
    Score: 0.074
  72. Gaddam S, Singh M, Balasubramanian G, Thota P, Gupta N, Wani S, Higbee AD, Mathur SC, Horwhat JD, Rastogi A, Young PE, Cash BD, Bansal A, Vargo JJ, Falk GW, Lieberman DA, Sampliner RE, Sharma P. Persistence of nondysplastic Barrett's esophagus identifies patients at lower risk for esophageal adenocarcinoma: results from a large multicenter cohort. Gastroenterology. 2013 Sep; 145(3):548-53.e1.
    View in: PubMed
    Score: 0.073
  73. Anaparthy R, Gaddam S, Kanakadandi V, Alsop BR, Gupta N, Higbee AD, Wani SB, Singh M, Rastogi A, Bansal A, Cash BD, Young PE, Lieberman DA, Falk GW, Vargo JJ, Thota P, Sampliner RE, Sharma P. Association between length of Barrett's esophagus and risk of high-grade dysplasia or adenocarcinoma in patients without dysplasia. Clin Gastroenterol Hepatol. 2013 Nov; 11(11):1430-6.
    View in: PubMed
    Score: 0.073
  74. Giacchino M, Bansal A, Kim RE, Singh V, Hall SB, Singh M, Rastogi A, Moloney B, Wani SB, Gaddam S, Mathur SC, Wallace MB, Kanakadandi V, Balasubramanian G, Gupta N, Sharma P. Clinical utility and interobserver agreement of autofluorescence imaging and magnification narrow-band imaging for the evaluation of Barrett's esophagus: a prospective tandem study. Gastrointest Endosc. 2013 May; 77(5):711-8.
    View in: PubMed
    Score: 0.071
  75. Gupta N, Gaddam S, Wani SB, Bansal A, Rastogi A, Sharma P. Longer inspection time is associated with increased detection of high-grade dysplasia and esophageal adenocarcinoma in Barrett's esophagus. Gastrointest Endosc. 2012 Sep; 76(3):531-8.
    View in: PubMed
    Score: 0.068
  76. Sharma P, Hawes RH, Bansal A, Gupta N, Curvers W, Rastogi A, Singh M, Hall M, Mathur SC, Wani SB, Hoffman B, Gaddam S, Fockens P, Bergman JJ. Standard endoscopy with random biopsies versus narrow band imaging targeted biopsies in Barrett's oesophagus: a prospective, international, randomised controlled trial. Gut. 2013 Jan; 62(1):15-21.
    View in: PubMed
    Score: 0.066
  77. Gaddam S, Mathur SC, Singh M, Arora J, Wani SB, Gupta N, Overhiser A, Rastogi A, Singh V, Desai N, Hall SB, Bansal A, Sharma P. Novel probe-based confocal laser endomicroscopy criteria and interobserver agreement for the detection of dysplasia in Barrett's esophagus. Am J Gastroenterol. 2011 Nov; 106(11):1961-9.
    View in: PubMed
    Score: 0.065
  78. Singh M, Bansal A, Curvers WL, Kara MA, Wani SB, Alvarez Herrero L, Lynch CR, van Kouwen MC, Peters FT, Keighley JD, Rastogi A, Pondugula K, Kim R, Singh V, Gaddam S, Bergman JJ, Sharma P. Observer agreement in the assessment of narrowband imaging system surface patterns in Barrett's esophagus: a multicenter study. Endoscopy. 2011 Sep; 43(9):745-51.
    View in: PubMed
    Score: 0.064
  79. Gupta N, Bansal A, Wani SB, Gaddam S, Rastogi A, Sharma P. Endoscopy for upper GI cancer screening in the general population: a cost-utility analysis. Gastrointest Endosc. 2011 Sep; 74(3):610-624.e2.
    View in: PubMed
    Score: 0.064
  80. Alvarez Herrero L, Curvers WL, Bansal A, Wani S, Kara M, Schenk E, Schoon EJ, Lynch CR, Rastogi A, Pondugula K, Weusten B, Sharma P, Bergman JJ. Zooming in on Barrett oesophagus using narrow-band imaging: an international observer agreement study. Eur J Gastroenterol Hepatol. 2009 Sep; 21(9):1068-75.
    View in: PubMed
    Score: 0.056
  81. Pondugula K, Wani S, Sharma P. Barrett's esophagus and esophageal adenocarcinoma in adults: long-term GERD or something else? Curr Gastroenterol Rep. 2007 Dec; 9(6):468-74.
    View in: PubMed
    Score: 0.050
  82. Rastogi A, Puli S, El-Serag HB, Bansal A, Wani S, Sharma P. Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: a meta-analysis. Gastrointest Endosc. 2008 Mar; 67(3):394-8.
    View in: PubMed
    Score: 0.050
  83. Sharma P, Wani S, Rastogi A. Endoscopic therapy for high-grade dysplasia in Barrett's esophagus: ablate, resect, or both? Gastrointest Endosc. 2007 Sep; 66(3):469-74.
    View in: PubMed
    Score: 0.049
  84. Sharma P, Wani S. Advances in esophageal imaging: practical applications for clinicians. Rev Gastroenterol Disord. 2006; 6 Suppl 1:S12-8.
    View in: PubMed
    Score: 0.044
  85. Wani S, Sharma P. The rationale for screening and surveillance of Barrett's metaplasia. Best Pract Res Clin Gastroenterol. 2006; 20(5):829-42.
    View in: PubMed
    Score: 0.044
  86. Pratap A, Qualman A, Garrett H, The E, Chauhan A, Idrovo JP, Cheng L, Wani S, Meguid RA, Meng X. Targeting Glypican-1 Reverses Resistance to 5-Fluorouracil in Esophageal Adenocarcinoma Cells. Anticancer Res. 2023 Aug; 43(8):3411-3418.
    View in: PubMed
    Score: 0.037
  87. Sharma P, Wani S, Bansal A. The quest for intestinal metaplasia--is it worth the effort? Am J Gastroenterol. 2007 Jun; 102(6):1162-5.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)